Unit Three - Core Attitudes
- Page ID
- 234470
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)
( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\id}{\mathrm{id}}\)
\( \newcommand{\Span}{\mathrm{span}}\)
\( \newcommand{\kernel}{\mathrm{null}\,}\)
\( \newcommand{\range}{\mathrm{range}\,}\)
\( \newcommand{\RealPart}{\mathrm{Re}}\)
\( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)
\( \newcommand{\Argument}{\mathrm{Arg}}\)
\( \newcommand{\norm}[1]{\| #1 \|}\)
\( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)
\( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)
\( \newcommand{\vectorA}[1]{\vec{#1}} % arrow\)
\( \newcommand{\vectorAt}[1]{\vec{\text{#1}}} % arrow\)
\( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vectorC}[1]{\textbf{#1}} \)
\( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)
\( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)
\( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)
\( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)
\(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)- 3.1: Addiction and the Brain- Development, Not Disease
- This page examines addiction through contrasting perspectives: the disease model, which frames it as a brain disorder influenced by neurobiology, and the developmental-learning model, which views it as a learned behavior rooted in normal brain processes and habits. The former emphasizes the need for medical approaches, while the latter highlights personal agency and neuroplasticity in recovery.
- 3.2: The Neurobiology of Substance Use, Misuse, and Addiction
- This page examines the neurobiological mechanisms of addiction, particularly focusing on key brain regions like the basal ganglia, extended amygdala, and prefrontal cortex. It describes the cyclical nature of addiction, encompassing three stages: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation, influenced by various risk factors including genetics, early life experiences, and co-occurring mental health disorders.
- 3.5: Stigma and Addiction
- This page emphasizes the need for non-stigmatizing language regarding addiction and substance use disorders (SUD). It highlights that stigma stems from misconceptions, leading to negative stereotypes that hinder help-seeking behaviors. The text advocates for person-first language, urging the use of respectful terms that distinguish individuals from their conditions.
- 3.6: Case Management
- This page emphasizes the critical role of case management in substance abuse treatment, addressing the complex needs of clients through three phases: pretreatment, primary treatment, and aftercare. It highlights the necessity for structured approaches that include assessment and advocacy, and the importance of tailored interventions to foster trust and client engagement.
- 3.7: Comprehensive Case Management for Substance Use Disorder Treatment
- This page discusses the importance of case management for patients with substance use disorders (SUDs) and co-occurring mental health issues. It emphasizes the growth of case management in U.S. treatment programs and its role in enhancing patient engagement and retention. Key factors driving demand include the integration of medical and behavioral health and health crises.
- 3.8: Finding Quality Treatment For Substance Use Disorders
- This page offers guidance from the Substance Abuse and Mental Health Services Administration on accessing behavioral health treatment. It details three preparatory steps: contacting insurance, exploring state funding for the uninsured, and evaluating provider quality through five indicators. Additionally, it includes treatment locators for substance use and mental health services, and advises calling 911 or visiting an emergency room in emergencies.
- 3.10: Clinical Supervision and Professional Development of the Substance Abuse Counselor
- This page emphasizes the crucial role of clinical supervision in substance abuse treatment, focusing on the integration of theoretical knowledge with practical skills, cultural competence, and ethical standards. Key elements include the supervisor-supervisee relationship, tailored supervision methods, gatekeeping functions, management of dual relationships, and the importance of documentation.
- 3.12: Frequently Asked Questions- Applying the Substance Abuse Confidentiality Regulations to Health Information Exchange (HIE)
- This page discusses the regulations on substance abuse confidentiality by SAMHSA and ONC, particularly focusing on the necessity of patient consent for sharing information within health information exchanges (HIEs) under Part 2 regulations. It outlines the conditions for using Qualified Service Organization Agreements (QSOAs), the requirements for consent forms, and the handling of patient information during medical emergencies.
- 3.13: Disclosure Of Substance Use Disorder Patient Records- Does Part 2 Apply To Me?
- This page summarizes the 42 CFR Part 2 Program, which safeguards the confidentiality of Substance Use Disorder (SUD) patient records since 1975, outlining the need for patient consent for disclosures. It presents examples involving healthcare providers within Accountable Care Organizations (ACOs), specifically Dr. Fillmore, a Part 2 provider, and Dr. Pierce, who is not, highlighting compliance with Part 2 and HIPAA.
- 3.14: Ethics Related to Mental Illnesses and Addictions
- This page reviews the complexities of mental health and addiction ethics, emphasizing the need for understanding, genuine engagement, and humane treatment in healthcare. It critiques media portrayals, societal double standards, and the balance between safety and autonomy. Issues of resource allocation, stigma, and systemic barriers to care are explored, along with the emerging field of neuroethics and the importance of comprehensive and equitable approaches.